Yüklüyor......
A proposal for dose-adjustment of dabigatran etexilate in atrial fibrillation guided by thrombin time
Dabigatran is an oral anticoagulant that is increasingly used for atrial fibrillation (AF). Presently, many authorities state that routine laboratory coagulation monitoring is not required. However, data have recently been published demonstrating that higher trough plasma dabigatran concentrations a...
Kaydedildi:
| Yayımlandı: | Br J Clin Pharmacol |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BlackWell Publishing Ltd
2014
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4243910/ https://ncbi.nlm.nih.gov/pubmed/24592851 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12364 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|